Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-09

Clinical Trial Update: Clobazam in Subjects With Lennox-Gastaut Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating clobazam in Lennox-Gastaut syndrome completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: Lundbeck LLC | Conditions: Epilepsy, Epilepsy, Generalized | Phase 2 | Status: COMPLETED | Results posted: 2012-02-09